125 related articles for article (PubMed ID: 23487173)
21. Cost-effectiveness of dabigatran and rivaroxaban compared with warfarin for stroke prevention in patients with atrial fibrillation.
Wang Y; Xie F; Kong MC; Lee LH; Ng HJ; Ko Y
Cardiovasc Drugs Ther; 2014 Dec; 28(6):575-85. PubMed ID: 25319314
[TBL] [Abstract][Full Text] [Related]
22. Laboratory monitoring of the non-vitamin K oral anticoagulants.
Blann AD; Lip GY
J Am Coll Cardiol; 2014 Sep; 64(11):1140-2. PubMed ID: 25212649
[No Abstract] [Full Text] [Related]
23. Neither dabigatran nor rivaroxaban were linked to increased GI bleeding compared with warfarin.
Koretz RL
Ann Intern Med; 2015 Sep; 163(6):JC13. PubMed ID: 26370028
[No Abstract] [Full Text] [Related]
24. Laboratory monitoring of anticoagulant medications: focus on novel oral anticoagulants.
Baruch L
Postgrad Med; 2013 Mar; 125(2):135-45. PubMed ID: 23816779
[TBL] [Abstract][Full Text] [Related]
25. Dabigatran and rivaroxaban use in atrial fibrillation patients on hemodialysis.
Chan KE; Edelman ER; Wenger JB; Thadhani RI; Maddux FW
Circulation; 2015 Mar; 131(11):972-9. PubMed ID: 25595139
[TBL] [Abstract][Full Text] [Related]
26. Performance of coagulation tests in patients on therapeutic doses of rivaroxaban. A cross-sectional pharmacodynamic study based on peak and trough plasma levels.
Francart SJ; Hawes EM; Deal AM; Adcock DM; Gosselin R; Jeanneret C; Friedman KD; Moll S
Thromb Haemost; 2014 Jun; 111(6):1133-40. PubMed ID: 24401946
[TBL] [Abstract][Full Text] [Related]
27. [New oral anticoagulants in the treatment of venous thromboembolic disease].
Calvo Romero JM; Lima Rodríguez EM
Semergen; 2013 Apr; 39(3):146-9. PubMed ID: 23540987
[TBL] [Abstract][Full Text] [Related]
28. Effect of non-specific reversal agents on anticoagulant activity of dabigatran and rivaroxaban: a randomised crossover ex vivo study in healthy volunteers.
Marlu R; Hodaj E; Paris A; Albaladejo P; Cracowski JL; Pernod G
Thromb Haemost; 2012 Aug; 108(2):217-24. PubMed ID: 22627883
[TBL] [Abstract][Full Text] [Related]
29. Dabigatran, ROCKET atrial fibrillation, and beyond: basic science, mechanisms of agents, monitoring, and reversal.
Bauer KA
Stroke; 2013 Jun; 44(6 Suppl 1):S38-40. PubMed ID: 23709725
[No Abstract] [Full Text] [Related]
30. New oral anticoagulants for the treatment of venous thromboembolism.
Agnelli G; Becattini C; Franco L
Best Pract Res Clin Haematol; 2013 Jun; 26(2):151-61. PubMed ID: 23953903
[TBL] [Abstract][Full Text] [Related]
31. [Update on current care guidelines: atrial fibrillation].
Käypä hoito -suosituksen päivitystiivistelmä
Duodecim; 2012; 128(4):374-6. PubMed ID: 22448550
[TBL] [Abstract][Full Text] [Related]
32. The laboratory and the new oral anticoagulants.
Tripodi A
Clin Chem; 2013 Feb; 59(2):353-62. PubMed ID: 23043068
[TBL] [Abstract][Full Text] [Related]
33. Novel anticoagulants and laboratory testing.
Eby C
Int J Lab Hematol; 2013 Jun; 35(3):262-8. PubMed ID: 23590653
[TBL] [Abstract][Full Text] [Related]
34. Meta-analysis of efficacy and safety of rivaroxaban compared with warfarin or dabigatran in patients undergoing catheter ablation for atrial fibrillation.
Aryal MR; Ukaigwe A; Pandit A; Karmacharya P; Pradhan R; Mainali NR; Pathak R; Jalota L; Bhandari Y; Donato A
Am J Cardiol; 2014 Aug; 114(4):577-82. PubMed ID: 24998087
[TBL] [Abstract][Full Text] [Related]
35. Should the newer oral anticoagulants be withheld from patients with valvular AF?
Dalen JE
Chest; 2013 Aug; 144(2):369-370. PubMed ID: 23918100
[No Abstract] [Full Text] [Related]
36. A new era of anticoagulation.
Hainaut PH
Acta Clin Belg; 2012; 67(6):394-8. PubMed ID: 23340143
[No Abstract] [Full Text] [Related]
37. An indirect comparison of dabigatran, rivaroxaban and apixaban for atrial fibrillation.
Mantha S; Ansell J
Thromb Haemost; 2012 Sep; 108(3):476-84. PubMed ID: 22740145
[TBL] [Abstract][Full Text] [Related]
38. ["Xa-tra-xa": opportunities and open questions about new anticoagulants].
Beer JH
Praxis (Bern 1994); 2011 Aug; 100(16):947. PubMed ID: 21910293
[No Abstract] [Full Text] [Related]
39. Review of recently approved alternatives to anticoagulation with warfarin for emergency clinicians.
Brem E; Koyfman A; Foran M
J Emerg Med; 2013 Jul; 45(1):143-9. PubMed ID: 23375217
[TBL] [Abstract][Full Text] [Related]
40. Newer anticoagulants for the prevention of venous thromboembolism.
Jaggia A
Natl Med J India; 2012; 25(1):22-5. PubMed ID: 22680317
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
